Table 1 Baseline characteristics of ADHF patients (n = 217)

Age (years)

66.18 ± 13.60

Male, n (%)

141 (64.98)

BMI (kg/m²)

24.82 ± 3.65

SBP (mmHg)

141.22 ± 24.99

Heart rate (bmp)

91.61 ± 23.46

Prior NYHA class I–II/III–IV, n (%)

50/167 (23.04/76.96)

Peripheral edema, n (%)

127 (58.53)

Hypertension, n (%)

124 (57.14)

CAD, n (%)

98 (45.16)

AF, n (%)

85 (39.17)

Diabetes mellitus, n (%)

60 (27.65)

COPD, n (%)

23 (10.60)

Hemoglobin (g/dl)

12.69 ± 2.18

Sodium < 135 mmol/L, n (%)

14 (6.45)

SCr (umol/L)

94.00 (79.00, 120.50)

LDL-c (mmol/L)

2.45 (1.73, 3.15)

HbA1c (%)

6.00 (5.70, 7.00)

PCT (pg/ml)

0.064 (0.038, 0.12)

sST2 (ng/ml)

19.63 (12.61, 35.53)

PIIINP (ng/ml)

6.70 (4.84, 9.96)

NT-proBNP (pg/ml)

4491.00 (1814.50, 8436.00)

LVEF (%)

45.00 (32.00, 58.75)

ACEI/ARB, n (%)

184 (84.79)

β-blocker, n (%)

157 (72.35)

Loop diuretic, n (%)

202 (93.09)

Aldosterone antagonist, n (%)

189 (87.10)